lidocaine viscous

Lidocaine viscous solution is a local anesthetic that is applied topically to treat painful mucous membranes or throat pain associated with oral diseases and for procedures involving the mouth or throat.

Lidocaine provides pain relief by inhibiting the influx of sodium ions involved in the initiation and conduction of nerve impulses associated with the perception of pain. Lidocaine is a local amide anesthetic that is thought to reversibly block nerve conduction and thereby provide local pain relief.

What brand names are available for lidocaine viscous?

Xylocaine Viscous 2%

Is lidocaine viscous available as a generic drug?

Yes

Do I need a prescription for lidocaine viscous?

Yes

Common side effects are associated with the local application of lidocaine and may include stinging, burning, and mild nausea.

Serious adverse effects include:

• allergic or anaphylactic reactions,
• drowsiness,
• dizziness,
• confusion,
• low blood pressure,
• irregular heartbeats,
• cardiac arrest,
• blurry vision,
• seizures, and
• breathing problems.

Seizures, heart and lung failure, and death occurred when children less than three were treated with lidocaine viscous solution.

To provide anesthesia before the insertion of medical instruments or catheters into the upper respiratory or digestive tracts, 10 to 15 ml (200 to 300 mg) is recommended not to exceed 400 mg/day.

To treat diseases of the upper gastrointestinal tract, 5 to15 ml of lidocaine is recommended not to exceed 60 ml or 1200 mg per day.

• Adults: 5-10 ml of lidocaine viscous is recommended for the treatment of painful mucous membranes of the mouth or throat. No more than 6 doses should be given in 24 hours and the maximum dose is 60 ml or 1200 mg lidocaine.
• Children 2-12 years: Dosing is based on weight. Do not exceed 1 ml per 5 kg of the child's weight per dose. Do not exceed 4 mg/kg or 4 doses in 24 hours.

Lidocaine topical administration results in low systematic or blood levels are therefore does not have any known clinically significant drug-drug interactions. The following drug interactions have been observed with intravenous lidocaine use.

Toxicity may result when the lidocaine is used with other local anesthetics or drugs which are structurally related to amide-type local anesthetics. Antiarrhythmic drugs such as mexiletine and amiodarone may increase blood concentrations of lidocaine.

Lidocaine is mainly metabolized or broken down by liver enzymes. Strong inhibitors of these liver enzymes such as fluvoxamine, erythromycin, and itraconazole may decrease the breakdown of lidocaine and cause an increase in its blood concentrations.

Cimetadine and beta-blockers such as propranolol may decrease blood levels of lidocaine by decreasing blood flow to the liver or by inhibiting liver enzymes that break down lidocaine.

Lidocaine has not been adequately evaluated in pregnant women.

Lidocaine and its metabolites are secreted into breast milk. At therapeutic doses the secretions in the breast milk are small and generally do not harm the infant; patients should consult their doctors before taking this drug.

Oromucosal solution: 2% (20 mg/mL)

Lidocaine Viscous should be stored at 15 C – 30 C (59 F – 86 –F).